Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Izuralimab |
Trade Name | |
Synonyms | XmAb 23104|XmAb23104 |
Drug Descriptions |
Izuralimab (XmAb23104) is a bispecific antibody that binds to PD-1 (PDCD1) and ICOS (inducible T-cell costimulator, CD278), potentially resulting in enhanced anti-tumor immune response (Cancer Res 2018;78(13 Suppl):Abstract nr 2784). |
DrugClasses | PD-L1/PD-1 antibody 121 |
CAS Registry Number | 2329669-80-7 |
NCIT ID | C157578 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Izuralimab | Izuralimab | 0 | 2 |
Izuralimab + XmAb22841 | Izuralimab XmAb22841 | 0 | 1 |